Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 24. Отображено 24.
02-06-2016 дата публикации

EPITOPE OF HEPATITIS B VIRUS SURFACE ANTIGEN AND BINDING MOLECULE SPECIFICALLY BINDING TO SAME FOR NEUTRALIZING HEPATITIS B VIRUS

Номер: WO2016085284A1
Принадлежит:

The present invention relates to an epitope specific to hepatitis B virus surface antigen and a binding molecule binding to the same for neutralizing hepatitis B virus. Since the epitope provided by the present invention is produced by forming a three-dimensional structure and does not comprise a determinant, by which escape mutation is induced against an administration of existing vaccines or HBIg, a composition comprising an antibody biding to the epitope or a vaccine composition comprising the epitope has a very low possibility of causing a decrease in efficacy due to escape mutation. Therefore, such an antibody or vaccine composition can be very effectively used in prevention and/or treatment of HBV.

Подробнее
25-02-2016 дата публикации

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер: KR0101597100B1
Принадлежит: (주)셀트리온

... 본 발명은 항체의 라이신 잔기에 직접 결합할 수 있는 효소-분해형 펩타이드 링커를 통해 항체와 세포독성 약물이 접합된 항체-링커-약물 결합체, 그의 제조방법 및 그를 유효성분으로 포함하는 항암제 조성물을 제공한다.

Подробнее
04-12-2014 дата публикации

BINDING MOLECULE ABLE TO NEUTRALISE HEPATITIS B VIRUS

Номер: WO2014193122A1
Принадлежит:

The present invention relates to a binding molecule having a hepatitis B virus neutralising action by binding to at least one member selected from the group consisting of hepatitis B virus surface antigen (HBsAg) subtypes adw, adr, ayw and ayr. The binding molecule of the present invention is highly useful in the prevention and treatment of hepatitis B since the binding molecule has an outstanding ability to bind to HBsAg and so can bind to all of the four main subtypes of HBV namely adw, adr, ayw and ayr and exhibits an effect in neutralising same, and exhibits a widespread neutralising effect extending to various mutant antigens of HBsAg.

Подробнее
20-11-2014 дата публикации

METHOD FOR REMOVING IMPURITIES BY USING CALCIUM PHOSPHATE PRECIPITATION

Номер: WO2014185716A1
Принадлежит:

The present invention relates to a method for removing impurities in a sample containing proteins, comprising a step of causing calcium phosphate to precipitate by adding a calcium ion solution and a phosphate ion solution to the sample containing proteins. It is possible to effectively remove impurities such as protein aggregates within a short time and by a simple method if purifying proteins by using the present invention instead of chromatography, which takes a long time and has a complex equipment and method in a purification process after protein A chromatography.

Подробнее
27-03-2014 дата публикации

DOLASTATIN-10 DERIVATIVE, METHOD OF PRODUCING SAME AND ANTICANCER DRUG COMPOSITION CONTAINING SAME

Номер: WO2014046441A1
Принадлежит:

The present invention provides a dolastatin-10 derivative having excellent anticancer activity, a method of producing the same and anticancer drug composition containing the same as an active principle.

Подробнее
02-10-2014 дата публикации

COMPOSITION COMPRISING AT LEAST TWO INFLUENZA A VIRUS-NEUTRALIZING-BINDING MOLECULES

Номер: WO2014158001A1
Принадлежит:

The present invention provides a composition which comprises at least two influenza A virus-neutralizing-binding molecules binding an epitope within a stem region of a hemagglutinin (HA) protein of an influenza A virus, wherein the composition comprises: i) a first binding molecule which can neutralize at least one influenza A virus subtype which is selected from the group consisting of H1, H2, H5 and H9; ii) a second binding molecule which can neutralize at least one influenza A virus subtype which is selected from the group consisting of H1, H3, H5, H7 and H9. The mixed composition of the present invention effectively neutralizes both multiple influenza subtypes of phylogeny groups 1 and 2, and can be used jointly with chemical compounds, and thus is very effective in preventing and treating disease caused by an influenza virus.

Подробнее
25-02-2016 дата публикации

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер: KR0101597110B1
Принадлежит: (주)셀트리온

... 본 발명은 항체의 라이신 잔기에 직접 결합할 수 있는 효소-분해형 펩타이드 링커를 통해 항체와 세포독성 약물이 접합된 항체-링커-약물 결합체, 그의 제조방법 및 그를 유효성분으로 포함하는 항암제 조성물을 제공한다.

Подробнее
08-06-2016 дата публикации

EPITOPE OF HEPATITIS B VIRUS SURFACE ANTIGEN AND HEPATITIS B VIRUS NEUTRALIZATION BINDING MOLECULE SPECIFICALLY COUPLED WITH SAME

Номер: KR1020160065021A
Принадлежит:

The present invention relates to a specific epitope of a hepatitis B virus surface antigen and a hepatitis B virus neutralization binding molecule coupled with same. The epitope provided according to the present invention has a three-dimensional structure and does not include an a crystallizer for producing an evasion mutation with respect to administration of a conventional vaccine or HBIg, so a composition including an antibody coupled therewith or a vaccine composition including the epitope has a very low possibility that an effect is decreased by an evasion mutation. Accordingly, such an antibody or vaccine composition may be very useful in preventing and/or treating HBV. COPYRIGHT KIPO 2016 ...

Подробнее
29-08-2016 дата публикации

펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물

Номер: KR0101652204B1
Принадлежит: (주)셀트리온

... 본 발명은 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 유효성분으로 포함하는 화장료 조성물을 제공한다. 본 발명의 펩타이드가 결합된 아스코르빈산 유도체는 멜라닌 생성 억제를 통한 미백 효과 및 콜라겐 생성 활성화를 통한 주름개선 효과를 동시에 나타내는 이중복합 기능을 가지며, 화장료 조성물에 사용될 수 있다.

Подробнее
18-12-2017 дата публикации

PROTECTOR FOR PROTECTING UNDERGROUND PIPES AND INSTALLATION METHOD THEREOF

Номер: KR1020170138845A
Принадлежит:

The present invention relates to a protector for protecting underground pipes and an installation method thereof, which can reduce earth pressure applied to the pipes, and improve an insulating property and durability of the pipes. The protector is manufactured by the following steps of: selecting and inputting a vinyl material; melting the vinyl material at a predetermined temperature; drawing out the melted vinyl material to an artificial lightweight aggregate having the predetermined shape; cooling the artificial lightweight aggregate at a predetermined temperature for a predetermined time through primary and secondary stages; and cutting the artificial lightweight aggregate cooled in the cooling step to a predetermined length. COPYRIGHT KIPO 2018 ...

Подробнее
02-06-2016 дата публикации

STABLE PEPTIDE-CONJUGATED ASCORBIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION CONTAINING SAME

Номер: WO2016085127A2
Принадлежит:

The present invention provides a stable peptide-conjugated ascorbic acid derivative, a method for preparing the same, and a cosmetic composition containing the same as an active ingredient. The peptide-conjugated ascorbic acid derivative of the present invention has a dual complex function of exhibiting a whitening effect through melanogenesis inhibition and a wrinkle reduction effect through collagenesis activation at the same time, and can be used for a cosmetic composition.

Подробнее
25-02-2016 дата публикации

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер: KR0101597105B1
Принадлежит: (주)셀트리온

... 본 발명은 항체의 라이신 잔기에 직접 결합할 수 있는 효소-분해형 펩타이드 링커를 통해 항체와 세포독성 약물이 접합된 항체-링커-약물 결합체, 그의 제조방법 및 그를 유효성분으로 포함하는 항암제 조성물을 제공한다.

Подробнее
25-02-2016 дата публикации

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер: KR0101597101B1
Принадлежит: (주)셀트리온

... 본 발명은 항체의 라이신 잔기에 직접 결합할 수 있는 효소-분해형 펩타이드 링커를 통해 항체와 세포독성 약물이 접합된 항체-링커-약물 결합체, 그의 제조방법 및 그를 유효성분으로 포함하는 항암제 조성물을 제공한다.

Подробнее
15-03-2018 дата публикации

B형 간염 바이러스 표면 항원의 에피토프 및 이에 특이적으로 결합하는 B형 간염 바이러스 중화 결합 분자

Номер: KR0101839101B1
Принадлежит: (주)셀트리온

... 본 발명은 B형 간염 바이러스 표면 항원의 특이적 에피토프와 이에 결합하는 B형 간염 바이러스 중화 결합 분자에 관한 것이다. 본 발명이 제공하는 에피토프는 3차원적 구조를 형성함으로써 생성되며 기존의 백신 또는 HBIg 투여에 대한 회피 돌연변이가 생성되는 a 결정기를 포함하지 않기 때문에, 여기에 결합하는 항체를 포함하는 조성물 또는 상기 에피토프를 포함하는 백신 조성물은 회피 돌연변이에 의한 효능의 저하가 일어날 가능성이 매우 낮다. 따라서 이러한 항체 또는 백신 조성물은 HBV의 예방 및/또는 치료에 매우 유용하게 사용될 수 있다.

Подробнее
28-07-2016 дата публикации

칼슘인산염 침전을 이용한 불순물 제거 방법

Номер: KR0101642551B1
Принадлежит: (주)셀트리온

... 본 발명은 단백질 함유 시료에 칼슘 이온 용액과 인산 이온 용액을 첨가하여 칼슘인산염 침전 반응을 형성하는 단계를 포함하는, 단백질 함유 시료 중의 불순물을 제거하는 방법에 관한 것이다. 본 발명을 이용하여 단백질을 정제하는 경우, 단백질 A 크로마토그래피 이후 정제 공정에서 긴 시간과 설비와 방법이 복잡한 크로마토그래피 대신에, 단백질 다량체와 같은 불순물을 효과적으로 짧은 시간과 단순한 방법으로 제거할 수 있다.

Подробнее
31-03-2017 дата публикации

SHEARING STRENGTH EVALUATION DEVICE FOR FROZEN GROUND AND FROZEN GROUND SHEARING STRENGTH CALCULATION METHOD USING SAME

Номер: KR1020170035757A
Принадлежит:

According to an embodiment of the present invention, a shearing strength evaluation device for frozen ground comprises: a rod unit having a conic cone unit installed on one end thereof and a guide unit installed on the other end thereof to be inserted into frozen ground; a pressing unit connected to the guide unit to be vertically moved to press the rod unit to insert the conic cone unit into the frozen ground while falling along the guide unit; a strain gage installed in the conic cone unit to sense strain of the conic cone unit in an electric resistance value when the pressing unit presses the rod unit to measure a force (F) when the conic cone unit is inserted into the frozen ground; an accelerometer installed in the conic cone unit to sense acceleration at which the conic cone unit is inserted in the frozen ground when the pressing unit presses the rod unit; and a calculation unit to receive the force (F) measured by the strain gage and the acceleration measured by the accelerometer ...

Подробнее
06-10-2016 дата публикации

COMPOSITE CONTAINING TWO OR MORE INFLUENZA A VIRUS NEUTRALIZATION BINDING MOLECULES

Номер: KR1020160115875A
Принадлежит:

The present invention relates to a composite containing two or more influenza A virus neutralization binding molecules combined to an epitope inside a stem region of hemagglutinin (HA) protein of an influenza A virus. The present invention provides the composite comprising: i) a first binding molecule capable of neutralizing one or more influenza A virus sub types selected from a group which is formed of H1, H2, H5, and H9; and ii) a second binding molecule capable of neutralizing one or more influenza A virus sub types selected from a group which is formed of H1, H3, H5, H7, and H9. A mixed composite of the present invention can effectively neutralize multiplex influenza sub types of 1 and 2 system generation groups and can be used with a chemical compound. Therefore, the mixed composite can be useful for the prevention and treatment of a disease by an influenza virus. COPYRIGHT KIPO 2016 ...

Подробнее
10-07-2014 дата публикации

ANTIBODY-LINKER-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND ANTICANCER DRUG COMPOSITION CONTAINING SAME

Номер: WO2014107024A1
Принадлежит:

The present invention relates to an antibody-linker-drug conjugate in which an antibody and a cytotoxic drug are conjugated through an enzyme cleavable peptide linker capable of directly binding to a lysine residue of an antibody, a preparation method therefor, and an anticancer drug composition containing the same as an active ingredient.

Подробнее
24-05-2017 дата публикации

광견병 바이러스를 중화시킬 수 있는 결합 분자

Номер: KR0101739313B1
Принадлежит: (주)셀트리온

... 본 발명은 광견병 바이러스를 중화시킬 수 있는 결합 분자에 관한 것으로, 더욱 상세하게 본 발명의 결합 분자는 개, 소, 몽구스, 박쥐, 스컹크, 너구리, 코요테, 여우 및 늑대와 같은 개체에서 유래한 광견병 바이러스를 대상으로 중화하는 능력을 가지고 있으므로, 광범위한 개체에서 유래한 광견병 바이러스에 감염된 환자를 치료하는데 유용하게 이용될 수 있다.

Подробнее
02-06-2016 дата публикации

STABLE PEPTIDE-CONJUGATED ASCORBIC ACID DERIVATIVE, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION CONTAINING SAME

Номер: WO2016085127A3
Принадлежит:

The present invention provides a stable peptide-conjugated ascorbic acid derivative, a method for preparing the same, and a cosmetic composition containing the same as an active ingredient. The peptide-conjugated ascorbic acid derivative of the present invention has a dual complex function of exhibiting a whitening effect through melanogenesis inhibition and a wrinkle reduction effect through collagenesis activation at the same time, and can be used for a cosmetic composition.

Подробнее
07-06-2016 дата публикации

STABLE PEPTIDE-CONJUGATED ASCORBIC ACID DERIVATIVE, PRODUCING METHOD THEREOF, AND COSMETIC COMPOSITION COMPRISING SAME

Номер: KR1020160063976A
Принадлежит:

The present invention provides a stable peptide-conjugated ascorbic acid derivative, a producing method thereof, and a cosmetic composition comprising the same as an active ingredient. The peptide-conjugated ascorbic acid derivative of the present invention has a dual complex function of exhibiting a whitening effect through melanogenesis inhibition and a wrinkle reduction effect through collagenesis activation at the same time, and can be used for a cosmetic composition. COPYRIGHT KIPO 2016 ...

Подробнее
01-12-2016 дата публикации

2 이상의 인플루엔자 A 바이러스 중화 결합 분자를 포함하는 조성물

Номер: KR0101681550B1
Принадлежит: (주)셀트리온

... 본 발명은 인플루엔자 A 바이러스의 헤마글루티닌(HA) 단백질의 줄기 영역(stem region) 내 에피토프에 결합하는 2 이상의 인플루엔자 A 바이러스 중화 결합 분자를 포함하는 조성물로서, i) H1, H2, H5 및 H9으로 구성된 군으로부터 선택되는 하나 이상의 인플루엔자 A 바이러스 서브타입을 중화시킬 수 있는 제 1 결합 분자; 및 ii) H1, H3, H5, H7 및 H9으로 구성된 군으로부터 선택되는 하나 이상의 인플루엔자 A 바이러스 서브타입을 중화시킬 수 있는 제 2 결합 분자를 포함하는 조성물을 제공한다. 본 발명의 혼합 조성물은 계통발생 그룹 1 및 2의 다중 인플루엔자 서브타입 둘 다를 효과적으로 중화시키며, 화학적 화합물과도 병용하여 사용할 수 있으므로, 인플루엔자 바이러스로 인한 질환의 예방 및 치료에 매우 유용하다.

Подробнее
08-08-2016 дата публикации

B형 간염 바이러스를 중화시킬 수 있는 결합 분자

Номер: KR0101646830B1
Принадлежит: (주)셀트리온

... 본 발명은 B형 간염 바이러스 표면 항원(HBsAg) 서브타입 adw, adr, ayw, 및 ayr으로 구성된 군에서 선택되는 어느 하나 이상에 결합하여 B형 간염 바이러스에 중화 활성을 가지는 결합 분자에 관한 것이다. 본 발명의 결합 분자는 HBsAg에 대한 우수한 결합 능력을 가짐으로써 HBV의 adw, adr, ayw, ayr 4가지 주요 아형 모두에 결합 가능하고 중화 효과를 나타내며, HBsAg의 다양한 돌연변이 항원에까지 폭넓은 중화효과를 나타내므로, B형 간염 예방 및 치료에 매우 유용하다.

Подробнее
18-06-2015 дата публикации

BINDING MOLECULES CAPABLE OF NEUTRALIZING RABIES VIRUSES

Номер: WO2015088256A1
Принадлежит:

The present invention relates to binding molecules capable of neutralizing rabies viruses. More specifically, the binding molecules of the present invention have an ability to neutralize rabies viruses derived from subjects, such as a dog, a cow, a mongoose, a bat, a skunk, a raccoon, a coyote, a fox, and a wolf, and thus can be favorably used to treat patients infected with rabies viruses derived from a broad range of subjects.

Подробнее